β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells

Multidrug resistance (MDR) is a primary obstacle to curative cancer therapy. We have previously demonstrated that β-casein (β-CN) micelles (β-CM) can serve as nanovehicles for oral delivery and target-activated release of hydrophobic drugs in the stomach. Herein we introduce a novel nanosystem based on β-CM, to orally deliver a synergistic combination of a chemotherapeutic drug (Paclitaxel) and a P-glycoprotein-specific transport inhibitor (Tariquidar) individually encapsulated within β-CM, for overcoming MDR in gastric cancer. Light microscopy, dynamic light scattering and zeta potential analyses revealed solubilization of these drugs by β-CN, suppressing drug crystallization. Spectrophotometry demonstrated high loading capacity and good encapsulation efficiency, whereas spectrofluorometry revealed high affinity of these drugs to β-CN. In vitro cytotoxicity assays exhibited remarkable synergistic efficacy against human MDR gastric carcinoma cells with P-glycoprotein overexpression. Oral delivery of β-CN - based nanovehicles carrying synergistic drug combinations to the stomach constitutes a novel efficacious therapeutic system that may overcome MDR in gastric cancer.

[1]  Rahul P Gangwal,et al.  Oral delivery of anticancer drugs: challenges and opportunities. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[2]  J. Lyklema,et al.  Measurement and Interpretation of Electrokinetic Phenomena (IUPAC Technical Report) , 2005 .

[3]  A. el-Sharif,et al.  Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Sanyog Jain,et al.  Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes). , 2012, Molecular pharmaceutics.

[5]  Elizabeth Fox,et al.  Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor , 2007, Expert review of anticancer therapy.

[6]  J. Schellens,et al.  Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation , 2014, British Journal of Cancer.

[7]  Yoav D Livney,et al.  β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: stability, target-activated release and cytotoxicity. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  W. Xu,et al.  Cysteine modified and bile salt based micelles: preparation and application as an oral delivery system for paclitaxel. , 2015, Colloids and surfaces. B, Biointerfaces.

[9]  S. Nagini,et al.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. , 2012, World journal of gastrointestinal oncology.

[10]  Yoav D. Livney,et al.  Casein micelle as a natural nano-capsular vehicle for nutraceuticals , 2007 .

[11]  U. Cogan,et al.  Micellization of bovine beta-casein studied by isothermal titration microcalorimetry and cryogenic transmission electron microscopy. , 2006, Journal of agricultural and food chemistry.

[12]  M. Melamed,et al.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  G. Battogtokh,et al.  Self-assembled Chitosan-Ceramide Nanoparticle for Enhanced Oral Delivery of Paclitaxel , 2014, Pharmaceutical Research.

[14]  J. Adrian,et al.  Interaction between casein and vitamin A during food processing. , 1991, Advances in experimental medicine and biology.

[15]  Y. Assaraf.  Molecular basis of antifolate resistance , 2007, Cancer and Metastasis Reviews.

[16]  Yoav D Livney,et al.  Rationally designed nanovehicles to overcome cancer chemoresistance. , 2013, Advanced drug delivery reviews.

[17]  Jintian Tang,et al.  Pharmaceutical nanotechnology for oral delivery of anticancer drugs. , 2013, Advanced drug delivery reviews.

[18]  Y. Assaraf,et al.  Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[19]  Vladimir P Torchilin,et al.  Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. , 2011, International journal of pharmaceutics.

[20]  Yoav D Livney,et al.  Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[21]  Y. Assaraf,et al.  Beta-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[22]  C A Ghiron,et al.  Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies. , 1976, Biochemistry.

[23]  J. Majoral,et al.  Phosphorus Dendrimers as Carriers of siRNA—Characterisation of Dendriplexes , 2013, Molecules.

[24]  J. Kopeček,et al.  Hyaluronan Oligomers-HPMA Copolymer Conjugates for Targeting Paclitaxel to CD44-Overexpressing Ovarian Carcinoma , 2012, Pharmaceutical Research.

[25]  Yanli Zhao,et al.  Pluronic-poly (acrylic acid)-cysteine/Pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel , 2014, Drug development and industrial pharmacy.

[26]  D. Wilson,et al.  The interaction of sucrose esters with β-lactoglobulin and β-casein from bovine milk , 1992 .

[27]  Y. Assaraf,et al.  Lysosomes as mediators of drug resistance in cancer. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[28]  E. Warner,et al.  Patient preferences for oral versus intravenous palliative chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  A. Moosavi-Movahedi,et al.  Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application , 2011 .

[30]  Yehuda G Assaraf,et al.  Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[31]  Dinesh Kumar,et al.  Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. , 2012, Biomaterials.

[32]  J. Irache,et al.  Casein nanoparticles as carriers for the oral delivery of folic acid , 2015 .

[33]  D. Rousseau,et al.  Interactions of Vitamin D 3 with Bovine -Lactoglobulin A and -Casein , 2005 .

[34]  Yoav D Livney,et al.  Stability and bioavailability of vitamin D nanoencapsulated in casein micelles. , 2012, Food & function.

[35]  S. Ambudkar,et al.  Improving cancer chemotherapy with modulators of ABC drug transporters. , 2011, Current drug targets.

[36]  Yun Cai,et al.  Bioavailability Enhancement of Paclitaxel via a Novel Oral Drug Delivery System: Paclitaxel-Loaded Glycyrrhizic Acid Micelles , 2015, Molecules.

[37]  Clive G. Wilson,et al.  Physiological pharmaceutics : biological barriers to drug absorption , 1989 .

[38]  G. Kellogg,et al.  A molecular model to explain paclitaxel and docetaxel sensitivity changes through adduct formation with primary amines in electrospray ionization mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[39]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[40]  Y. Zambito,et al.  Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan. , 2013, Carbohydrate polymers.

[41]  D. Dalgleish,et al.  A study of β-casein tertiary structure by intramolecular crosslinking and mass spectrometry , 2004 .

[42]  V. Torchilin,et al.  PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells , 2012, Drug delivery.

[43]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .

[44]  H. Sampson,et al.  In vitro digestibility of bovine β-casein with simulated and human oral and gastrointestinal fluids. Identification and IgE-reactivity of the resultant peptides. , 2014, Food chemistry.

[45]  Y. D. Livney,et al.  Milk proteins as vehicles for bioactives , 2010 .

[46]  Y. Assaraf,et al.  Beta-casein Nanoparticles as an Oral Delivery System for Chemotherapeutic Drugs: Impact of Drug Structure and Properties on Co-assembly , 2010, Pharmaceutical Research.

[47]  T. Dutta,et al.  Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of Paclitaxel , 2011, AAPS PharmSciTech.

[48]  J. Mano,et al.  Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation. , 2013, Carbohydrate polymers.

[49]  P. More,et al.  Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel. , 2013, Biomacromolecules.

[50]  J. Pedraz,et al.  Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research , 2012, Clinical and Translational Oncology.

[51]  J. Benoit,et al.  Lipid nanocapsules: a new platform for nanomedicine. , 2009, International journal of pharmaceutics.

[52]  Christin Müller,et al.  Tariquidar Analogues: Synthesis by CuI‐Catalysed N/O–Aryl Coupling and Inhibitory Activity against the ABCB1 Transporter , 2007 .

[53]  J. Panyam,et al.  Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Yechezkel Barenholz,et al.  Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.